Topic number
1 . 2021
Assessment of cardiovascular risks and possibility of their pharmacological correction
Content
Editorial

Dear collegues!

Abstract
Original research

Efficacy of empagliflozine in experimental chronic heart failure in normoglycemia

Abstract
A comparative experimental study of the empagliflozin efficacy of (intragastric 1 mg/kg) in monotherapy in the treatment of experimental chronic heart failure (CHF) in normoglycemia was conducted. Pathology was modeled by permanent ligation of the left coronary artery. One

Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction

Abstract
Acute myocardial infarction (MI) patients remain at high risk for recurrent events. Cholesterol efflux, mediated by apolipoprotein A-I, removes excess cholesterol from atherosclerotic plaque and transports it to the liver for excretion. Impaired cholesterol efflux is

Therapeutic effects of triple antiplatelet therapy in elderly female patients with diabetes and acute myocardial infarction

Abstract
Background . Dual antiplatelet therapy (DAPT) is the cornerstone treatment of acute myocardial infarction (AMI). Objective . The present study aimed to investigate the efficacy and safety of triple antiplatelet therapy (TAPT) in elderly female patients with diabetes and ST

Drug-induced cardiotoxicity associated with the use of antitumor antibiotics

Abstract
The risk of developing cardiotoxicity against the background of the antibiotic use with antitumor activity is one of the most pressing problems in modern oncology and cardiology. Cardiotoxic complications significantly impair the life quality of patients and shorten lifespan

Common pathogenesis of cardiovascular diseases and inflammatory processes of the oral cavity and maxillofacial region from the standpoint of the relationship of systemic proinflammatory biomarkers

Abstract
The severity of inflammatory processes in the maxillofacial region can be associated not only with local inflammation, but also with systemic processes in the body, which can aggravate the course of cardiovascular diseases. Against the background of periodontal diseases,

Assessment of the prognosis of cardiovascular risks in individuals with arterial hypertension and oral inflammatory processes

Abstract
It is established that the presence of inflammatory processes of the oral cavity increases the cardiovascular risk. Paradontal pathology, which leads to increased expression of proinflammatory cytokines, affects the atherosclerosis initiation, endothelial dysfunction,
Clinical саses

Differential diagnostics of takotsubo syndrome and acute myocardial infarction against the background of a new COVID-19 coronavirus infection

Abstract
Takotsubo syndrome is an acutely occurring heart failure syndrome characterized by transient systolic dysfunction and extensive akinesia of the apical and/or middle segments of the left ventricle (LV). Its clinical significance lies in the similarity of the clinical picture

A clinical dicussion of acute myocarditis behind the mask of myocardial infarction with non-obstructive coronary arteries

Abstract

The article presents a clinical case of acute viral myocarditis in a young patient manifested like myocardial infarction with non-obstructive coronary arteries.

Сontinuous medical education

Formation of the right heart chambers in norm and pathology

Abstract
The review article presents various structures of the right heart, which can occur both in norm and in pathology. The possibilities of diagnostics and differential diagnostics of normal anatomical variants and pathological masses by means of echocardiography are considered.
Clinical tests

Clinical tests

Abstract
Cardiology news

News (# 1, 2021)

Abstract
Announcements

Announcements (# 1, 2021)

Abstract

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Andrey G. Obrezan
MD, Professor, Head of the Hospital Therapy Department of the Saint Petersburg State University, Chief Physician of SOGAZ MEDICINE Clinical Group, St. Petersburg, Russian Federation

Journals of «GEOTAR-Media»